Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
Thierry Burnouf, Vice-Dean, Distinguished Professor, Biomedical Engineering at Taipei Medical University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in APL Bioengineering, adding:
”We are pleased to share our new review paper: ‘Platelet membrane-coated nanoparticles: bioengineering principles, quality control, and translational opportunities’
This review discusses the rapidly evolving field of platelet membrane-coated nanoparticles and their potential applications in nanomedicine, regenerative medicine, and targeted drug delivery.
Authors: Nobile Bagezile Mdlovu, liling delila, Si-Han Wu, and Thierry Burnouf
Work conducted at Taipei Medical University (TMU), Taiwan.”
Title: Platelet membrane-coated nanoparticles: Bioengineering principles, quality control, and translational opportunities Featured
Authors: Nobile Bagezile Mdlovu, liling delila, Si-Han Wu, Thierry Burnouf
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 7, 2026, 03:00Sandeep Kumar: A Second Chance for a Child with Fanconi Anemia
-
Oct 7, 2026, 02:41Kemal Karaagac: Optimising DOAC Resumption After Major Bleeding in Atrial Fibrillation
-
Oct 7, 2026, 02:21Joseph Aslan: mPTP Inhibition Targets Platelet Procoagulant Activity and Thrombosis
-
Oct 7, 2026, 02:07Manuel Monreal: ECG Improves Risk Stratification in Acute Pulmonary Embolism
-
Oct 6, 2026, 22:43Alessandra Bosch: Pediatric GTH Opens with Regional Experts Convening on Pediatric Hemostasis and Thrombosis
-
Oct 6, 2026, 22:39Managing Thrombotic Risk in Pregnancy – How the Lab May Help – Sysmex Europe
-
Oct 6, 2026, 22:33Ahmet Davut Aksu: A Multi-Objective Approach to Enhance Fibrinolysis, Selectivity, and Inhibition Resistance
-
Oct 6, 2026, 22:29Muhammad Abubakar: New Study on Iron Biology to Be Presented at ASH 2026 and Published in Blood
-
Oct 6, 2026, 22:24David McIntosh: Calling On Decision-Makers to Prioritize Donors and Clinical Access During IPAW 2026